On December 4, 2025 at 1:13 PM

New Cannabis Ventures offers readers this easy-to-read exclusive summary of BDSA’s 15-state monthly cannabis sales data.

Cannabis sales rose 3.4% sequentially in October, a 0.1% daily gain. In this review, we break down the results by state, starting with the western markets and then ending with the eastern markets. Overall, the BDSA estimates sales in 15 markets totaled $2.11 billion in October, up 5.8 percent from a year earlier. Excluding the big gain in New York, which I explain below, sales were down 2.7%. Note that BDSA has revised some data historically.

Western markets

BDSA provides coverage for Arizona, California, Colorado, Nevada and Oregon. In September, the annual growth was negative in 3 states. In four of these states, daily growth declined sequentially.

Eastern markets

BDSA provides coverage for Florida, Illinois, Maryland, Massachusetts, Michigan, Missouri, New Jersey, New York, Ohio and Pennsylvania. Annual growth in September ranged from -6.5% in New Jersey to +1,513.2% in New York, whose adult-use sales have been included by the BDSA since January but were first included a few months ago. Ohio began using adults in August, spurring growth. Note that Florida and Pennsylvania are medical markets only. Sequential growth was flat in most markets, helped by an extra day and negative in one market. Annual growth was negative in several markets and increased sharply in two states. We warned of a potential slowdown in Florida despite strong dispensary and unit volume growth due to competitive pressure, and it has now declined for two consecutive months.

For readers interested in a deeper look hemp markets in these fifteen states and more, including segmentation by additional product categories, brand and product details, longer history and segmentation by product attributes, learn how BDSA Solutions can give you access to actionable data and analytics.

Based in Houston, Alan leverages his experience as an online community founder 420 Investorthe first and still the largest due diligence platform focused on publicly traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. time New Cannabis Ventureshe is responsible for content development and strategic alliances. Before turning his attention to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst with more than two decades of research and portfolio management experience. A prolific writer, with over 650 articles published since 2007 Looking for Alphawhere he has 70,000 followers, Alan is a frequent speaker at industry conferences and frequent source Media including the NY Times, Wall Street Journal, Fox Business and Bloomberg TV. Contact Alan. Twitter: |: Facebook |: LinkedIn: |: El